| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2007.
MEMO TO THE MEDIA |
Press Release
Bisphosphonate Treatment Is Associated with Jaw Bone Problems
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
| The first 10% of the full text of this article appears below. |
Patients treated with intravenous bisphosphonates are at an increased risk of jaw or facial bone deterioration or infection, according to a study published online June 26 in the Journal of the National Cancer Institute.
Several recent studies have found an association between the use of intravenous bisphosphonates and osteonecrosis of the jaw or facial bones, a
Note to Reporters:
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 1016-1024.
J Natl Cancer Inst 2007 99: 986-987.